Terms: = Thyroid cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
220 results:
1. Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma.
Gao Z; An P; Li R; Wu F; Sun Y; Wu J; Yang G; Wang Z
Cancer Imaging; 2024 Feb; 24(1):25. PubMed ID: 38336821
[TBL] [Abstract] [Full Text] [Related]
2. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
3. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
4.
Chen L; Zheng S; Chen L; Xu S; Wu K; Kong L; Xue J; Chen X; Miao W; Zhu Y
J Nucl Med; 2023 Dec; 64(12):1899-1905. PubMed ID: 37918866
[No Abstract] [Full Text] [Related]
5. Diagnostic Performance of thyroid Nodule Risk Stratification Systems: Comparison of ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA Guidelines.
Yucel S; Balci IG; Tomak L
Ultrasound Q; 2023 Dec; 39(4):206-211. PubMed ID: 37918114
[TBL] [Abstract] [Full Text] [Related]
6. Methylation-Mediated Silencing of ATF3 Promotes thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
7. Clinical value of grayscale ultrasound combined with real-time shear wave elastography nomogram in risk prediction of thyroid cancer.
Ren T; Jiang M; Wu J; Zhang F; Zhang C
BMC Med Imaging; 2023 Sep; 23(1):123. PubMed ID: 37700270
[TBL] [Abstract] [Full Text] [Related]
8. Digital analyses of nuclear features can help discriminate among non-invasive follicular thyroid neoplasm with papillary-like nuclear features, papillary thyroid carcinoma follicular subtype, and follicular carcinoma in cytological specimens.
Yamamoto FM; Liano LC; Camilo-Júnior DJ; Xavier-Junior JCC
Cytopathology; 2024 Jan; 35(1):98-104. PubMed ID: 37688777
[TBL] [Abstract] [Full Text] [Related]
9. Improved organ sparing using auto-planned Stanford volumetric modulated arc therapy for total body irradiation technique.
Ngo N; Blomain ES; Simiele E; Romero I; Hoppe RT; Hiniker SM; Kovalchuk N
Pediatr Blood Cancer; 2023 Oct; 70(10):e30589. PubMed ID: 37486149
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of thyroid fine needle aspiration biopsy and ultrasonography results.
Keskin L; Karahan D; Yaprak B
Medicine (Baltimore); 2023 Jun; 102(26):e33822. PubMed ID: 37390290
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of the Efficiency of Radiofrequency and Microwave Ablation Methods in the Treatment of Benign thyroid Nodules.
Cerit MN; Yücel C; Cerit ET; Yalçın MM; Şendur HN; Oktar SÖ
Acad Radiol; 2023 Oct; 30(10):2172-2180. PubMed ID: 37357048
[TBL] [Abstract] [Full Text] [Related]
12. Theranostic Surrogacy of [
Kim SB; Lee MS; Song IH; Park HS; Kim SE
Mol Pharm; 2023 Jul; 20(7):3460-3470. PubMed ID: 37294909
[TBL] [Abstract] [Full Text] [Related]
13. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
Sarswat S; Khan D; Sagar S; Kumar R
Nucl Med Commun; 2023 Aug; 44(8):726-731. PubMed ID: 37272295
[TBL] [Abstract] [Full Text] [Related]
14. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
Mauguen A; Grewal RK; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne J; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Tuttle RM; Ho A; Humm JL; Larson SM
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2971-2983. PubMed ID: 37171634
[TBL] [Abstract] [Full Text] [Related]
15. Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020).
Ribeiro TB; Bennett CL; Colunga-Lozano LE; Araujo APV; Hozo I; Djulbegovic B
J Clin Epidemiol; 2023 Jul; 159():151-158. PubMed ID: 37037322
[TBL] [Abstract] [Full Text] [Related]
16. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
[TBL] [Abstract] [Full Text] [Related]
17. Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the
von Guggenberg E; Uprimny C; Klinger M; Warwitz B; Sviridenko A; Bayerschmidt S; di Santo G; Virgolini IJ
J Nucl Med; 2023 Jun; 64(6):859-862. PubMed ID: 36657979
[TBL] [Abstract] [Full Text] [Related]
18. Predicting malignancy in thyroid nodules based on conventional ultrasound and elastography: the value of predictive models in a multi-center study.
Zhang Y; Huang QY; Wu CJ; Chen Q; Xia CJ; Liu BJ; Liu YY; Zhang YF; Xu HX
Endocrine; 2023 Apr; 80(1):111-123. PubMed ID: 36495391
[TBL] [Abstract] [Full Text] [Related]
19.
Rizzo A; Racca M; Cauda S; Balma M; Dall'Armellina S; Dionisi B; Mossetti C; Bruna MC; Freddi M; Palestini N
Endocrine; 2023 May; 80(2):433-440. PubMed ID: 36495390
[TBL] [Abstract] [Full Text] [Related]
20. [
Mu X; Huang X; Jiang Z; Li M; Jia L; Lv Z; Fu W; Mao J
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1205-1215. PubMed ID: 36495325
[TBL] [Abstract] [Full Text] [Related]
[Next]
